Unknown

Dataset Information

0

Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review.


ABSTRACT:

Background & aims

Fibrosis is the strongest predictor for long-term clinical outcomes among patients with non-alcoholic fatty liver disease (NAFLD). There is growing interest in employing non-invasive methods for risk stratification based on prognosis. FIB-4, NFS and APRI are models commonly used for detecting fibrosis among NAFLD patients. We aimed to synthesize existing literature on the ability of these models in prognosticating NAFLD-related events.

Methods

A sensitive search was conducted in two medical databases to retrieve studies evaluating the prognostic accuracy of FIB-4, NFS and APRI among NAFLD patients. Target events were change in fibrosis, liver-related event and mortality. Two reviewers independently performed reference screening, data extraction and quality assessment (QUAPAS tool).

Results

A total of 13 studies (FIB-4:12, NFS: 11, APRI: 10), published between 2013 and 2019, were retrieved. All studies were conducted in a secondary or tertiary care setting, with follow-up ranging from 1 to 20 years. All three markers showed consistently good prognostication of liver-related events (AUC from 0.69 to 0.92). For mortality, FIB-4 (AUC of 0.67-0.82) and NFS (AUC of 0.70-0.83) outperformed APRI (AUC of 0.52-0.73) in all studies. All markers had inconsistent performance for predicting change in fibrosis stage.

Conclusions

FIB-4, NFS, and APRI have demonstrated ability to risk stratify patients for liver-related morbidity and mortality, with comparable performance to a liver biopsy, although more head-to-head studies are needed to validate this. More refined models to prognosticate NAFLD-events may further enhance performance and clinical utility of non-invasive markers.

SUBMITTER: Lee J 

PROVIDER: S-EPMC7898346 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review.

Lee Jenny J   Vali Yasaman Y   Boursier Jerome J   Spijker Rene R   Anstee Quentin M QM   Bossuyt Patrick M PM   Zafarmand Mohammad H MH  

Liver international : official journal of the International Association for the Study of the Liver 20210201 2


<h4>Background & aims</h4>Fibrosis is the strongest predictor for long-term clinical outcomes among patients with non-alcoholic fatty liver disease (NAFLD). There is growing interest in employing non-invasive methods for risk stratification based on prognosis. FIB-4, NFS and APRI are models commonly used for detecting fibrosis among NAFLD patients. We aimed to synthesize existing literature on the ability of these models in prognosticating NAFLD-related events.<h4>Methods</h4>A sensitive search  ...[more]

Similar Datasets

| S-EPMC6023204 | biostudies-literature
| S-EPMC7891512 | biostudies-literature
| S-EPMC10701128 | biostudies-literature
| S-EPMC9240253 | biostudies-literature
| S-EPMC5561053 | biostudies-literature
| S-EPMC7412911 | biostudies-literature
| S-EPMC7893465 | biostudies-literature
| S-EPMC4764354 | biostudies-literature
| S-EPMC9244481 | biostudies-literature
| S-EPMC5542225 | biostudies-other